J. Ye, “Predictive levels of vascular endothelial growth factor (VEGF), thymidine kinase 1(TK1) with interleukin-6 (IL-6), plasma T cells, NK cells as well as B cells in treating diffuse large B-cell lymphoma receiving rituximab: Predictive levels of vascular endothelial growth factor (VEGF), thymidine kinase 1(TK1) with interleukin-6 (IL-6)”, J Med Biochem, vol. 44, no. 4, pp. 784–791, Mar. 2025, doi: 10.5937/jomb0-54911.